Skip to main content
Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia?
Racial disparities in the development of comorbid conditions after preterm birth: A narrative review.
Nativity and perinatal outcome disparities in the United States: Beyond the immigrant paradox.
How does the convergence of prematurity and congenital heart disease impact the developing brain?
Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.
Transcriptional profiling of the ductus arteriosus: Comparison of rodent microarrays and human RNA sequencing.
Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity.
Early neurodevelopmental outcomes of extremely preterm infants.
History and current status of newborn screening for severe combined immunodeficiency.
The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.